A2 Biotherapeutics (A2 Bio) is a clinical-stage biotechnology company headquartered in Agoura Hills, California, founded in 2018 by Alexander Kamb, Michael Gallo and Paul Kang. It develops logic-gated cell therapies for solid tumors on its proprietary Tmod platform, a two-receptor activator/blocker design that lets an engineered T cell attack… - View it on GitHub